Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2005
06/16/2005US20050130171 Complementary DNA library comprising nucleotide sequences expressed in brain for use as tool in diagnosis, prevention and treatment of cerebral and cognitive functioning disorders
06/16/2005US20050130170 Identification and verification of methylation marker sequences
06/16/2005US20050130169 Using chaperone and non-coding intergenic sequences as diagnostic tool in classification of intestinal flora
06/16/2005US20050130168 Using forward and reverse primer sequences associated with acid fast bacillus as diagnostic tool in classification of grampositive bacteria
06/16/2005US20050130167 Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring
06/16/2005US20050130165 Using presence of single nucleotide polymorphism in sterol-o-acyltransferase (SOAT1) and/or acyl-coenzyme A: cholesterol acyltransferase 1 (ACAT-1) as diagnostic indicator of brain disorders
06/16/2005US20050130163 Surface-enhanced resonance Raman scattering (SERRS) active polymer beads; for use in detecting targect molecules
06/16/2005US20050130162 Nucleotide sequences coding fatty acid acyl-CoA synthetase long-chain family member-4 (FACL4) for use as diagnostic tool in detection of brain disorders; restriction fragment length polymorphism
06/16/2005US20050130161 Identifying gene regulatory elements using methyltransferase and restriction enzyme disgestion; animal toxicity profiles; drug screening
06/16/2005US20050130159 Using immobilized enzymes to determine sequence of preferential nucleic acid; cleavage of single nucleotide building blocks and fluorescent imaging
06/16/2005US20050130158 Screening method
06/16/2005US20050130157 Improving resolution of macromolecules separation via pulse field electrophoresis
06/16/2005US20050130156 Methods for making polynucleotides and purifying double-stranded polynucleotides
06/16/2005US20050130155 Primers for the detection and identification of bacterial indicator groups and virulene factors
06/16/2005US20050130154 Compositions and methods relating to endometrial specific genes and proteins
06/16/2005US20050130153 Plasmid targeting vector comprising fluorescent protein for use visualization tool in confocal microscopy; automated cell sorting
06/16/2005US20050130151 Fragile X mental retardation protein (FMRP) binding site for use as tool in detection, treatment and prevention of cognitive and motor disorders
06/16/2005US20050130150 Using allelic variation in growth hormone as tool in diagnosis and treatment of growth hormone irregularities
06/16/2005US20050130149 Method for williams-beuren syndrome diagnosis
06/16/2005US20050130146 Histone deactylase for use in identifying modulators for prevention and treatment of cell proliferative disorders
06/16/2005US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening
06/16/2005US20050130143 Human smooth muscle myosin heavy chain polypeptide (hSMMyHC 7polypeptide) for use as tool in identifying modulator for prevention and treatment of hypertension, hypotension, heart and respiratory disorders
06/16/2005US20050130142 Forming double-stranded polynucleotide molecules
06/16/2005US20050130139 Method f amplifying dna chip signals
06/16/2005US20050130136 Cardiovascular disease diagnostic and therapeutic targets
06/16/2005US20050130135 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
06/16/2005US20050130134 Using site directed mutagenesis to identify sequence variation which e nhance viral susceptibility to delavirdine, nevirapine and efavirenz; viricides and treatment of lymphadenopathy associated viral disease
06/16/2005US20050130133 Oligonucleotide primers derived from west nile viral consensus sequence for use in classification, identification and diagnosis of viral infection; blood screening
06/16/2005US20050130131 Contacting macrophages in vitro with composition comprising hepatitis c viral particles, culture cells, incubate with non-macrophage cells, culture, recover viral particles; viricides and rational drug design
06/16/2005US20050130127 Coronavirus-like particles comprising functionally deleted genomes
06/16/2005US20050130124 Helper phage comprising conditional mutation in filamentous viral coat protein for use as tool in expression of heterologous gene products
06/16/2005US20050130120 Devices for the detection of multiple analytes in a sample
06/16/2005US20050130119 Real-time impedance assay to follow the invasive activities of metastatic cells in culture
06/16/2005US20050130118 Methods for identifying inhibitors of chlorophyll synthase
06/16/2005US20050130117 Using serine/threonine kinase screening tool in detection of modulator for prevention and treatment of inflammatory, respiratory, allergic and autoimmune diseases
06/16/2005US20050130116 Test system comprising cells expressing polymorphic cytochrome p450 for use as drug and toxicological screening tools; bioassay; rational drug design
06/16/2005US20050129727 Drug core encapsulated with multilayer polyelectrolyte shells
06/16/2005US20050129717 Novel uses
06/16/2005US20050129713 For use in vaccine
06/16/2005US20050129705 hepatitis C virus; for activating cytotoxic t lymphocytes in presence of major histomcompatibility complex
06/16/2005US20050129703 identifying T cells in a sample that become activated in the presence of a vaccinia or variola virus using immunogenic mutant or fragment of peptide 165 as a CD8 T cell epitope
06/16/2005US20050129702 Tick chitinase
06/16/2005US20050129700 comprises antibodies against Smallpox Inhibitor of Complement Enzyme (SPICE) or Vaccinia Virus Complement Control Protein (VCP); dna vaccines
06/16/2005US20050129697 Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides
06/16/2005US20050129694 At least one (SEK) kinase inhibitor that acts in an synergistic manner to those inhibiting the virus multiplication for the Raf/MEK/ERK signal transmission path; influenza viricides
06/16/2005US20050129657 Interferon-alpha induced gene
06/16/2005US20050129617 Contacting a T lymphocyte from the patient with a diagnostic epitope of an amino acid string including hydrophilic amino acids and one of Leucine, Methionine, Isoleucine, Phenylalanine, Alanine, Glycine, Valine, or Tryptophan
06/16/2005US20050129581 Microfluidic devices and methods of using same
06/16/2005US20050127035 Addressable nanopores and micropores including methods for making and using same
06/16/2005US20050127002 Linkage to photopolymerized sol-gel within column, pipet, well, and/or well plate
06/16/2005US20050126908 Electrochemical detector systems
06/16/2005DE10353887A1 Hochparalleler DNA-Synthesizer auf Matrizenbasis Highly parallel DNA synthesizer to die base
06/16/2005DE10353621A1 Oligonucleotide-peptide used in nucleic acid analysis, is made by covalent bonding of defined marker-peptide chain to oligonucleotide
06/16/2005DE10351717A1 Device for determining resistance to pharmaceuticals, used particularly for selection of anticancer agents, comprises an array of nucleic acid sequences or derived proteins from specific genes
06/16/2005DE102004046388A1 Quantifizierung von Nukleinsäuren unter Verwendung von Wachstumskurven Quantification of nucleic acids using growth curves
06/16/2005DE10131188B4 Screening method for identifying inhibitors of lipoprotein lipase, useful in pharmaceuticals and cosmetics, particularly for treatment of fatty deposits in the skin
06/16/2005DE10056802B4 Verfahren zur Detektion von Methylierungszuständen zur toxikologischen Diagnostik A method for the detection of methylation states for diagnosis toxicological
06/16/2005DE10029915B4 Verfahren zum Nachweis von Cytosin-Methylierungen A method for the detection of cytosine methylations
06/16/2005CA2765442A1 Novel centromeric protein shugoshin
06/16/2005CA2764400A1 Novel centromeric protein shugoshin
06/16/2005CA2764298A1 Novel centromeric protein shugoshin
06/16/2005CA2587863A1 Genes associated with colorectal cancer
06/16/2005CA2549913A1 Polymorphic cd24 genotypes that are predictive of multiple sclerosis risk and progression
06/16/2005CA2549835A1 Method for controlling electrodeposition of an entity and devices incorporating the immobilized entity
06/16/2005CA2549158A1 Methods of generating stem cells and embryonic bodies carrying disease-causing mutations and methods of using same for studying genetic disorders
06/16/2005CA2548528A1 Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
06/16/2005CA2548440A1 Method of measuring blood component, sensor used in the method, and measuring device
06/16/2005CA2548381A1 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target
06/16/2005CA2547885A1 Methods for obtaining gene tags
06/16/2005CA2547787A1 Compositions comprising fetal liver cells and methods useful for hcv infection
06/16/2005CA2547355A1 Animal models of pancreatic adenocarcinoma and uses therefor
06/16/2005CA2547317A1 Protein nmb1125 and use thereof in pharmaceutical formulations
06/16/2005CA2547226A1 Use of l-isoaspartyl methyltransferase as longevity marker in seeds
06/16/2005CA2546886A1 Method for sex biasing spermatozoa
06/16/2005CA2546848A1 Development of mammalian genome modification technique using retrotransposon
06/16/2005CA2546669A1 Sequence-specific inhibition of small rna function
06/16/2005CA2546448A1 Biomarkers for the efficacy of somatostatin analogue treatment
06/16/2005CA2546111A1 Biomarkers for the efficacy of calcitonin and parathyroid hormone treatment
06/16/2005CA2545581A1 Clp-protease as target for herbicides
06/16/2005CA2544577A1 Methods and compositions for immuno-histochemical detection
06/16/2005CA2490088A1 Test element for analysing sample material
06/15/2005EP1542019A2 Method of screening endothelial cells for angiogenic capability
06/15/2005EP1542015A1 Electrochemical determination of fructosamine
06/15/2005EP1542009A1 Method of detecting nucleic acid by using dna microarrays and nucleic acid detection apparatus
06/15/2005EP1542002A1 Biopolymer automatic identifying method
06/15/2005EP1542001A1 Solid support and method of mass spectrometry of multiple substances or composites immobilized on the solid support through desorption/ionization
06/15/2005EP1542000A1 Base sequence detecting device and base sequence automatic analyzer
06/15/2005EP1541698A2 Method of classifying gene expression strength in lung cancer tissues
06/15/2005EP1541697A1 Detection of group B streptococcus
06/15/2005EP1541696A1 A DNA macro-array for staphylococcus aureus identification and typing
06/15/2005EP1541695A1 Use of a mutation in the BRAF gene for the determination of the malignancy of melanoma cells
06/15/2005EP1541694A1 Methods of identifying, selecting and/or characterizing compounds which modulate the activity of a Src family kinase
06/15/2005EP1541685A1 Factor participating in transcriptional regulation
06/15/2005EP1541684A1 Smg-1-binding protein and method of screening substance controlling its activity
06/15/2005EP1541679A1 Method of analyzing organelle-localized protein and materials for analysis
06/15/2005EP1541586A1 Novel gene associated with rheumatoid arthritis
06/15/2005EP1540698A1 System and method for the preparation of arrays of biological or other molecules
06/15/2005EP1540590A1 Assay stick comprising coded microbeads
06/15/2005EP1540560A2 Metabolic phenotyping
06/15/2005EP1540351A1 Glucose extraction patch and its manufacturing process